




E ase of administration, accuracy, andconvenience are among the hallmarkcharacteristics of insulin pens. These
devices, which have gained popularity over
the past 10 years, are designed to be used
multiple times for a single person, using a
new needle for each injection. Unfortu-
nately, reports of themisuse of insulin pens
also have been growing.
Backflow of blood and other biologic
material into the insulin cartridge or
reservoir can occur after injection (1).
For this reason, insulin pens, like other
injection devices, must never be used by
more than one person. Reports of insulin
pen sharing have come from a variety of
U.S. health care settings. Since 2011, there
have been at least six separate incidents in
which patients were contacted and given
advice to test for bloodborne patho-
gens because individual insulin pen devices
were reused for multiple patients (Table 1).
In all of these events, reuse of pens
may have occurred over a period of years
before it was identified and corrected.
Because these unsafe practices had gone
unnoticed for so long, thousands of
patients were placed at risk for infection.
These incidents occurred in spite of clear
package instructions stating that pens
are not to be shared and a series of alerts
issued by the U.S. Food and Drug
Administration, the Centers for Disease
Control and Prevention, and other
groups such as the Institute for Safe
Medication Practices (2). In response to re-
cent incidents identified at Veterans Health
Administration (VHA) facilities, the VHA
issued a patient safety alert that, with few
exceptions, prohibits the use of multidose
pen injector devices, including insulin pens,
on patient-care units in the VHA system (3).
To help educate both health care
personnel and patients, the Safe Injection
Practices Coalition, led by the Centers for
Disease Control and Prevention, has de-
veloped an educational campaign and
materials addressing the safe use of insulin
pens (4). Anyone using insulin pens should
adhere to the following practices to ensure
that they do not place themselves or pa-
tients in their care at risk for infection.
c Insulin pens should never be used for
more than one person, even when the
needle is changed.
c Insulin pens should be clearly labeled
with the person’s name or other iden-
tifying information to ensure that the
correct pen is used exclusively on one
individual.
c Hospitals and other facilities that use
insulin pens and similar devices must
have policies addressing safe use, with
an active program to ensure that staff
are appropriately educated, in advance
of introducing these products, with
active monitoring to ensure strict ad-
herence to safe practices.
c If multipatient use is identified, ex-
posed persons should be promptly
notified and offered appropriate follow-
up including bloodborne pathogen
testing.
The Centers for Medicare &Medicaid
Services has instructed surveyors to eval-
uate the use of insulin pens when con-
ducting facility inspections and to cite
facilities that fail to follow safe practices
(5). However, facilities should not wait
for an inspection and should immedi-
ately evaluate current practices. After
all, protection from infections, including
those caused by bloodborne pathogens,
is a basic expectation anywhere health
care is provided.
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Table 1—Patient notification events resulting from multipatient use of insulin pens in U.S.















Hospitala 57 2001–2011 Wisconsin Division of Public
Health, unpublished data
Hospital 716 2010–2012 http://www.buffalonews.com/
apps/pbcs.dll/article?AID=/20130111/
CITYANDREGION/130119728/1002




Hospital 205 2010–2013 http://www.wbtv.com/story/
21546682/salisbury-va-insulin
Hospital NA 2007–2013 http://www.recordonlin.com/apps/
pbcs.dll/article?AID=/20130521/NEWS/
130529929
aInsulin demonstration pens were reused. bNotification also included patients that were potentially exposed
to reused finger-stick devices. NA, not available.
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